30 December 2011
Observations with impact on the indication for kinetic therapy in critically ill liver transplant patients
Moritz KleineABCDEF, Kai JoahnningBD, Lampros KousoulasB, Harald SchremCD, Frank LehnerBD, Hüseyin BektasD, Jürgen KlempnauerD, Stephan KaadenADAnn Transplant 2011; 16(4): 25-31 :: ID: 882215
Abstract
Background: Severe pulmonary complications following orthotopic liver transplantation are a major cause of postoperative deaths. Kinetic therapy (KT) has been reported to prevent and treat respiratory complications in selected critically ill patients, but little has been reported about the value of different criteria for the use of this therapy and its side effects in liver transplant recipients.
Material/Methods: We performed a prospective observational study of 27 patients treated post-transplantation in our ICU. 12 of 27 patients were treated with KT in case of either high number of blood transfusions (>20) or respiratory insufficiency (PaO2/FiO2 ratio <250 mmHg) or pretransplant pulmonary disease. Over a period of nine days we measured the PaO2/FiO2 ratio to evaluate the beneficial effect of KT. Liver perfusion was quantified by doppler ultrasound. Transplant function was measured by INR (international normalised ratio) and determination of indocyanine green elimination rate.
Results: Side effects on graft perfusion and graft function were not seen. 7 of 12 patients decreased in their PaO2/FiO2 ratio significantly 48 hours postoperative to 53% as compared to early postoperative level and recovered under KT during the observed time period nearly to the early postoperative level (95%; p<0.001). The units of perioperative blood transfusions, the MELD-score, the decrease of PaO2/FiO2 ratio 24 h after transplantation and retransplantation for initial non-functioning of the graft all pointed to a likely beneficial effect of KT.
Conclusions: We conclude that these criteria may be helpful to identify patients who are likely to benefit from KT.
Keywords: Liver Transplantation, respiratory failure, kinetic therapy, critically ill patients
In Press
08 Mar 2024 : Original article
Association of Coronary Calcium Score on Cardiac PET During Pre-Kidney Transplant Assessment with Persisten...Ann Transplant In Press; DOI: 10.12659/AOT.943532
14 Mar 2024 : Original article
Impact of Blood Products Transfusion on Patients in the Immediate Post-Lung Transplant Period: A Cohort StudyAnn Transplant In Press; DOI: 10.12659/AOT.943652
14 Mar 2024 : Case report
Treatment of Cavernous Transformation of Portal Vein Caused by Hepatic Cystic Echinococcosis Using Ex Vivo ...Ann Transplant In Press; DOI: 10.12659/AOT.942358
15 Mar 2024 : Review article
Approaches and Challenges in the Current Management of Cytomegalovirus in Transplant Recipients: Highlighti...Ann Transplant In Press; DOI: 10.12659/AOT.941185
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860